Ethical and legal aspects of teratogenic medications: the case of isotretinoin.
Moskop
J C
JC
East Carolina University School of Medicine, Greenville, NC, USA.
Smith
M L
ML
De Ville
K
K
D000152:Acne Vulgaris / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D026686:Beneficence; D000075202:Contraindications; D030881:Disclosure; D017277:Drug Approval; D004992:Ethics, Medical; D035082:Federal Government; D005260:Female; D033161:Government Regulation; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use; D007641:Keratolytic Agents / Q000627:therapeutic use; D016365:Liability, Legal; D026706:Paternalism; D026684:Personal Autonomy; D011247:Pregnancy; D037841:Pregnant People; D018570:Risk Assessment; D013723:Teratogens; D014481:United States; D014486:United States Food and Drug Administration
D007641:Keratolytic Agents; D013723:Teratogens; D015474:Isotretinoin